These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7932529)

  • 1. Novel dual inhibitors of 5-lipoxygenase and thromboxane A2 synthetase: synthesis and structure-activity relationships of 3-pyridylmethyl-substituted 2-amino-6-hydroxybenzothiazole derivatives.
    Hibi S; Okamoto Y; Tagami K; Numata H; Kobayashi N; Shinoda M; Kawahara T; Murakami M; Oketani K; Inoue T
    J Med Chem; 1994 Sep; 37(19):3062-70. PubMed ID: 7932529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production.
    Oketani K; Nagakura N; Harada K; Inoue T
    Eur J Pharmacol; 2001 Jun; 422(1-3):209-16. PubMed ID: 11430933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of (E)-3-(1,4-benzoquinonyl)-2-[(3-pyridyl)-alkyl]-2-propenoic acid derivatives that inhibit both 5-lipoxygenase and thromboxane A2 synthetase.
    Hibi S; Okamoto Y; Tagami K; Numata H; Kobayashi N; Shinoda M; Kawahara T; Harada K; Miyamoto K; Yamatsu I
    J Med Chem; 1996 Aug; 39(16):3148-57. PubMed ID: 8759636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of E3040, an inhibitor of 5-lipoxygenase and thromboxane synthase, on rat bowel damage induced by lipopolysaccharide.
    Oketani K; Inoue T; Murakami M
    Eur J Pharmacol; 2001 Sep; 427(2):159-66. PubMed ID: 11557269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of a novel dual inhibitor of thromboxane A2 synthetase and 5-lipoxygenase (E3040) via the direct coupling reaction of hydroquinone with 3-pyridinecarboxaldehyde.
    Komatsu Y; Minami N
    Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1614-6. PubMed ID: 8536337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon.
    Sakai H; Suzuki T; Murota M; Oketani K; Uchiumi T; Murakami M; Takeguchi N
    Br J Pharmacol; 2002 Jun; 136(3):383-90. PubMed ID: 12023941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inhibitors of thromboxane A2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species. Synthesis of a novel series of (3-pyridylmethyl)benzoquinone derivatives.
    Ohkawa S; Terao S; Terashita Z; Shibouta Y; Nishikawa K
    J Med Chem; 1991 Jan; 34(1):267-76. PubMed ID: 1992126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thromboxane A2 inhibition and antagonism on prostaglandin and leukotriene synthesis in glomerular immune injury.
    Lianos EA; Bresnahan BA
    J Lab Clin Med; 1999 Nov; 134(5):478-82. PubMed ID: 10560941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of thromboxane and other eicosanoid synthesis in the course of experimental inflammatory colitis.
    Vilaseca J; Salas A; Guarner F; Rodriguez R; Malagelada JR
    Gastroenterology; 1990 Feb; 98(2):269-77. PubMed ID: 2153086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of platelet thromboxane synthetase by sulfasalazine.
    Stenson WF; Lobos E
    Biochem Pharmacol; 1983 Jul; 32(14):2205-9. PubMed ID: 6135423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo.
    Tateson JE; Randall RW; Reynolds CH; Jackson WP; Bhattacherjee P; Salmon JA; Garland LG
    Br J Pharmacol; 1988 Jun; 94(2):528-39. PubMed ID: 2840160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane A2 synthetase inhibitors. 2. Syntheses and activities of tetrahydronaphthalene and indan derivatives.
    Kanao M; Watanabe Y; Kimura Y; Saegusa J; Yamamoto K; Kanno H; Kanaya N; Kubo H; Ashida S; Ishikawa F
    J Med Chem; 1989 Jun; 32(6):1326-34. PubMed ID: 2724303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of cyclooxygenase product generation by human peritoneal macrophages.
    Mackenzie R; Coles GA; Topley N; Powell WS; Williams JD
    Immunology; 1992 Aug; 76(4):648-54. PubMed ID: 1328041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
    Cozzi P; Giordani A; Menichincheri M; Pillan A; Pinciroli V; Rossi A; Tonani R; Volpi D; Tamburin M; Ferrario R
    J Med Chem; 1994 Oct; 37(21):3588-604. PubMed ID: 7932586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase.
    Martinez GR; Walker KA; Hirschfeld DR; Bruno JJ; Yang DS; Maloney PJ
    J Med Chem; 1992 Feb; 35(4):620-8. PubMed ID: 1311763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase and lipoxygenase metabolite synthesis by polymorphonuclear neutrophils: in vitro effect of dipyrone.
    Abbate R; Gori AM; Pinto S; Attanasio M; Paniccia R; Coppo M; Castellani S; Giusti B; Boddi M; Neri Serneri GG
    Prostaglandins Leukot Essent Fatty Acids; 1990 Oct; 41(2):89-93. PubMed ID: 2177201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis.
    Casellas F; Papo M; Guarner F; Antolín M; Segura RM; Armengol JR; Malagelada JR
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):221-6. PubMed ID: 7743303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
    de Chaffoy de Courcelles D; De Clerck F
    Eur J Pharmacol; 1990 Mar; 188(2-3):161-9. PubMed ID: 2318257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of thromboxane B2 and leukotriene B4 biosynthesis by two naturally occurring acetylenic fatty acids.
    Croft KD; Beilin LJ; Ford GL
    Biochim Biophys Acta; 1987 Oct; 921(3):621-4. PubMed ID: 2822134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
    Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
    Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.